$17.50-$0.52 (-2.89%)
Schwab Capital Trust - Schwab U.S. Large-Cap Growth Index Fund’s quoted price sits in the upper half of its reported 52-week range, 8.95% below the high.
Loading market information…
NASDAQ · FSMEX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Fidelity Select Portfolios - Medical Technology and Devices Portfolio’s quoted price sits in the upper half of its reported 52-week range, 11.65% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Fidelity Select Portfolios - Medical Technology and Devices Portfolio’s forward annual dividend is $13.08 per share, paid semi-annual. The forward yield is 22.58% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This fund typically commits a minimum of 80% of its capital to the securities of companies predominantly involved in the medical technology industry. This includes firms engaged in the research, development, manufacturing, distribution, or sale of medical equipment and related technologies, as well as those supporting drug discovery, and companies providing information technology services primarily to healthcare providers. Its holdings largely consist of common stocks, and it invests in both domestic and international issuers. This is designated as a non-diversified fund.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 04:22 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$17.50-$0.52 (-2.89%)
Schwab Capital Trust - Schwab U.S. Large-Cap Growth Index Fund’s quoted price sits in the upper half of its reported 52-week range, 8.95% below the high.
$45.78-$0.76 (-1.63%)
DFA U.S. Large Cap Growth Portfolio’s quoted price sits in the upper half of its reported 52-week range, 4.35% below the high.
$20.76-$0.38 (-1.8%)
Victory Trivalent International Small-Cap CL A’s quoted price sits in the lower half of its reported 52-week range, 8.59% below the high.
$16.85-$0.16 (-0.94%)
DFA International Sustainability Core 1 Portfolio’s quoted price sits in the upper half of its reported 52-week range, 5.87% below the high.
$28.34-$0.25 (-0.87%)
Transamerica International Equity I’s quoted price sits in the upper half of its reported 52-week range, 4.32% below the high.
$9.33$0.00 (0.0%)
CCM Community Impact Bond Fund Institutional Shares’s quoted price sits in the lower half of its reported 52-week range, 4.41% below the high.
$19.63-$0.54 (-2.68%)
Baron Emerging Markets Fund’s quoted price sits in the lower half of its reported 52-week range, 16.43% below the high.
$19.80-$0.55 (-2.7%)
Baron Emerging Markets Fd Inst Shs’s quoted price sits in the lower half of its reported 52-week range, 16.35% below the high.
